NasdaqGM - Nasdaq Real Time Price USD

Wave Life Sciences Ltd. (WVE)

6.59
+0.05
+(0.69%)
At close: May 9 at 4:00:00 PM EDT
6.66
+0.07
+(1.13%)
After hours: May 9 at 6:49:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
108,302
108,302
113,305
3,649
40,964
Operating Expense
218,705
218,705
181,301
166,369
167,980
Operating Income
-110,403
-110,403
-67,996
-162,720
-127,016
Other Income Expense
13,395
13,395
9,806
1,578
4,567
Pretax Income
-97,008
-97,008
-58,190
-161,142
-122,449
Tax Provision
0
0
-677
681
-204
Net Income Common Stockholders
-97,008
-97,008
-57,513
-161,823
-122,245
Diluted NI Available to Com Stockholders
-97,008
-97,008
-57,513
-161,823
-122,245
Basic EPS
-0.70
--
-0.54
-2.05
-2.36
Diluted EPS
-0.70
--
-0.54
-2.05
-2.36
Basic Average Shares
138,277.47
--
106,097.27
78,855.81
51,825.57
Diluted Average Shares
138,277.47
--
106,097.27
78,855.81
51,825.57
Total Operating Income as Reported
-110,403
-110,403
-67,996
-162,720
-127,016
Total Expenses
218,705
218,705
181,301
166,369
167,980
Net Income from Continuing & Discontinued Operation
-97,008
-97,008
-57,513
-161,823
-122,245
Normalized Income
-107,171
-107,171
-65,348.76
-163,126.93
-122,274.94
EBIT
-110,403
-110,403
-67,996
-162,720
-127,016
EBITDA
-101,740
-101,740
-58,790
-152,606
-117,181
Reconciled Depreciation
8,663
8,663
9,206
10,114
9,835
Net Income from Continuing Operation Net Minority Interest
-97,008
-97,008
-57,513
-161,823
-122,245
Total Unusual Items Excluding Goodwill
10,163
10,163
7,928
1,571
30
Total Unusual Items
10,163
10,163
7,928
1,571
30
Normalized EBITDA
-111,903
-111,903
-66,718
-154,177
-117,211
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
92.24
267.07
0.06
12/31/2021 - 11/11/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KRRO Korro Bio, Inc.
15.56
+1.04%
 
PRQR ProQR Therapeutics N.V.
1.6100
+3.87%
 
DYN Dyne Therapeutics, Inc.
11.41
+1.02%
 
ARWR Arrowhead Pharmaceuticals, Inc.
13.03
-1.66%
 
RYTM Rhythm Pharmaceuticals, Inc.
57.38
-5.50%
 
JANX Janux Therapeutics, Inc.
25.56
-3.07%
 
NUVL Nuvalent, Inc.
69.85
-2.44%
 
VYGR Voyager Therapeutics, Inc.
3.1700
-7.58%
 
KYMR Kymera Therapeutics, Inc.
30.07
-2.27%
 
QURE uniQure N.V.
12.79
+4.41%